Search Results 51-60 of 14122 for anti-TNF drugs

  1. A Study of the Effectiveness and Safety of Vedolizumab Compared to Adalimumab for Participants with Ulcerative Colitis - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness and safety of vedolizumab intravenous (IV) treatment compared to adalimumab subcutaneous (SC) ...

  2. Publications - Sunanda V. Kane, M.D. - Mayo Clinic

    Safety of anti-TNF agents in pregnancy. J Allergy Clin Immunol. 2021 Sep; 148 (3):661-667. View PubMed; Ramos GP, Dimopoulos C, McDonald NM, Janssens LP, Hung ...

  3. Clinical Trials - Mayo Clinic Research

    ... Anti TNF Therapy. Amended Protocol to Include a Lutikizumab Open-Label Sub-study in Subjects Naïve to Biologic Therapy. A Study to Assess Disease Activity ...

  4. Anti-seizure medications: Relief from nerve pain - Mayo Clinic

    Anti-seizure drugs designed to treat epilepsy often are used to control nerve pain associated with diabetes, shingles, and other types of nerve damage.

  5. A Study of the Efficacy and Safety of Etrolizumab in Ulcerative Colitis Participants Who Are Refractory to or Intolerant of Tumor Necrosis Factor (TNF) Inhibitors - Mayo Clinic

    Intolerance, loss response or failure to respond to treatment with at least one TNF-inhibitor within the previous 5 years; Washout of anti-TNF therapy for at ...

  6. A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis Patients Who Are Naive to TNF Inhibitors - Mayo Clinic

    18-80 years of age, inclusive · Moderately to severely active UC as determined by the Mayo Clinic Score assessment (MCS) · Naive to treatment with any anti-TNF ...

  7. Infliximab-qbtx (intravenous route) - Mayo Clinic

    Infliximab-qbtx injection is used alone or together with other medicines (eg, methotrexate) to reduce the symptoms and prevent the progression of moderate-to- ...

  8. Drugs and Supplements that Start with I - Mayo Clinic

    Adalimumab (subcutaneous route). Idacio. Also known as. Adalimumab-aacf ... Anti-inflammatory drugs, nonsteroidal (ophthalmic route). Ilevro. Also known ...

  9. Updates in interstitial lung disease: Current facets of anti-fibrotic therapy - Mayo Clinic

    Teng Moua, M.D., discusses recent clinical trials and current research into the treatment of idiopathic pulmonary fibrosis (IPF) and non-IPF-progressive ...

  10. A Study of RoActemra/Actemra (Tocilizumab) in Comparison to Etanercept in Patients With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors - Mayo Clinic

    Previous treatment with tocilizumab or etanercept. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for the ...